AcquirerTargetPrice
Agilent Technologies Inc. Seahorse Bioscience$235 million
Concordia Healthcare Corp.Amdipharm Mercury Limited$3.3 billion
Eprirus Biopharmaceuticals, Inc. Bioceros Holding B.V.$14.1 million
Biogen Inc. License to MT-1303$60 million
Apricus Biosciences, Inc. U.S. rights to Vitaros™$1 million